Researchers have designed the first “living medicine” to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria that is naturally resistant to many types of antibiotics and is a common source of infections in hospitals.
'Living medicine' created to tackle drug-resistant lung infections
